Results 11 to 20 of about 6,879 (203)
Melancholic features related to rimonabant [PDF]
Obesity is currently considered a global epidemic and its prevention and treatment is a major public health concern, demanding treatment which may combine a sociocultural approach, lifestyle modification, nutritional, pharmacological or surgical strategies.
Bernardo, de Mattos Viana +2 more
core +4 more sources
The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant [PDF]
Rimonabant is the first CB1 receptor inhibitor available in the Brazilian market. This new drug has been approved for the treatment of obese or overweight patients associated with cardiovascular risk factors. In this article it is compared the effects of
Murro Ada
doaj +2 more sources
(+)-Trans-Cannabidiol Is an Agonist at Human CB<sub>2</sub> Receptors. [PDF]
ABSTRACT (−)‐trans‐Cannabidiol ((−)‐CBD) is a principal phytocannabinoid from Cannabis sativa. (−)‐CBD has complex pharmacology but is a relatively weak inhibitor of CB1 and CB2 receptor signaling. Cannabidiol has two chiral centres and thus four stereoisomers.
Burtchaell PB +6 more
europepmc +2 more sources
Rimonabant-induced depression in schizophrenia
Sir, Cannabinoids modulate mood probably through serotonergic neurons in medial prefrontal cortex and cannabinoid receptor (CB1) receptor antagonists may reverse these effects.
Arasappa, Rashmi +6 more
openaire +3 more sources
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. [PDF]
OBJECTIVE Blockade of the CB1 receptor is one of the promising strategies for the treatment of obesity. Although antagonists suppress food intake and reduce body weight, the role of central versus peripheral CB1 activation on weight loss and related ...
Nogueiras, Ruben +27 more
core +3 more sources
Introduction: The endocannabinoid system has been implicated in the neurobiology of opioid use disorder. While the CB1 receptor antagonist rimonabant has been shown to block some of the behavioral effects of opioids, studies suggest that the treatment ...
Eduardo A. V. Marinho +12 more
doaj +1 more source
Sevoflurane is widely used for maternal anesthesia during pregnancy. Sevoflurane exposure of rats at mid-gestation can cause abnormal development of the central nervous system in their offspring.
Yuxiao Wan +3 more
doaj +1 more source
Depression-like phenotype following chronic CB1 receptor antagonism
Rimonabant was the first clinically marketed cannabinoid (CB)1 receptor antagonist developed to treat obesity. Unfortunately, CB1 receptor antagonism produced adverse psychiatric events in patients.
Chad E. Beyer +11 more
doaj +1 more source
The endocannabinoid system is found throughout the CNS and the body where it impacts many important physiological processes. Expectations were high that targeting cannabinoid receptors would prove therapeutically beneficial; pharmaceutical companies ...
Taryn Bosquez-Berger +2 more
doaj +1 more source
Ein Cannabinoid-Rezeptorblocker, der bei Adipösen die Gewichtsabnahme begünstigt. Ein Nutzen bei anderen Indikationen konnte bisher nicht gezeigt werden. Die Substanz kann verschiedene neuropsychiatrische Nebenwirkungen verursachen.
openaire +1 more source

